LoginSignup
Fresenius logo

Fresenius Stock

StockStock
ISIN: DE0005785604
Ticker: FRE
DE0005785604
FRE

Price

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 23.05.2025

$0.406

CHART BY

Frequently asked questions

What is Fresenius's market capitalization?

The market capitalization of Fresenius is $20.51B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Fresenius?

Fresenius's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.148. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Fresenius's stock?

Currently, 20 analysts cover Fresenius's stock, with a consensus target price of $39.14. Analyst ratings provide insights into the stock's expected performance.

What is Fresenius's revenue over the trailing twelve months?

Over the trailing twelve months, Fresenius reported a revenue of $23.93B.

What is the EBITDA for Fresenius?

Fresenius's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $4.39B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Fresenius?

Fresenius has a free cash flow of $3.19B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Fresenius's stock?

The 5-year beta for Fresenius is 1.05. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Fresenius have, and what sector and industry does it belong to?

Fresenius employs approximately 175,771 people. It operates in the Health Care sector, specifically within the Healthcare Facilities industry.

What is the free float of Fresenius's shares?

The free float of Fresenius is 411.39M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $20.51B

5Y beta

 1.05

EPS (TTM)

 -$2.148

Free Float

 411.39M

Revenue (TTM)

 $23.93B

EBITDA (TTM)

 $4.39B

Free Cashflow (TTM)

 $3.19B

Pricing

1D span
$36.23$36.66
52W span
$26.20$38.80

Analyst Ratings

The price target is $39.14 and the stock is covered by 20 analysts.

Buy

14

Hold

6

Sell

0

Information

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.

175,771

Healthcare Facilities

Health Care

Identifier

ISIN

DE0005785604

Primary Ticker

FRE

Knockouts

Join the conversation
Sign upLogin